未登录
分享
收藏
分享
收藏
分享
收藏Discovery of Novel Non-nucleoside DOT1LR231Q Inhibitors with Improved Pharmacokinetic Properties and Anti-lung Cancer Efficacy
Tan, Zehui; Guo, Ning; Liu, Shuyu; Li, Jiandong; Chen, Yu; Cui, Jianming; Lei, Hongrui; Jiang, Nan; Wang, Lihui; Zhai, Xin
分享
收藏Discovery of first-in-class DOT1L inhibitors against the R231Q gain-of-function mutation in the catalytic domain with therapeutic potential of lung cancer
Tan, Zehui; Guo, Ning; Cao, Zhi; Liu, Shuyu; Zhang, Jiayu; Ma, Deyi; Zhang, Jiahao; Lv, Wencai; Jiang, Nan; Zang, Linghe; Wang, Lihui; Zhai, Xin
分享
收藏Gain-of-function mutations in the catalytic domain of DOT1L promote lung cancer malignant phenotypes via the MAPK/ERK signaling pathway
Zhang, Jiayu; Yang, Ting; Han, Mei; Wang, Xiaoxuan; Yang, Weiming; Guo, Ning; Ren, Yong; Cui, Wei; Li, Shangxiao; Zhao, Yongshan; Zhai, Xin; Jia, Lina; Yang, Jingyu; Wu, Chunfu; Wang, Lihui
分享
收藏
分享
收藏